248 related articles for article (PubMed ID: 19489659)
1. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
[TBL] [Abstract][Full Text] [Related]
2. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
3. Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma.
Goyal R; Chalamalasetty SB; Madan K; Paul SB; Arora R; Safaya R; Acharya SK
Indian J Gastroenterol; 2007; 26(6):292-3. PubMed ID: 18431015
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
Tavares-Bello R
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
[No Abstract] [Full Text] [Related]
5. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
Do JE; Kim YC
Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
[TBL] [Abstract][Full Text] [Related]
6. [Hand-foot syndrome with capecitabine therapy].
Marini A; Hengge UR
Hautarzt; 2007 Jun; 58(6):532-6. PubMed ID: 16897045
[TBL] [Abstract][Full Text] [Related]
7. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
Lee SD; Kim HJ; Hwang SJ; Kim YJ; Nam SH; Kim BS
Korean J Intern Med; 2007 Jun; 22(2):109-12. PubMed ID: 17616027
[TBL] [Abstract][Full Text] [Related]
8. [Capecitabine-induced hyperpigmentation].
Vázquez-Bayo C; Rodríguez-Bujaldón AL; Jiménez-Puya R; Galán-Gutiérrez M; Moreno-Giménez JC
Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine and hand-foot syndrome.
Saif MW
Expert Opin Drug Saf; 2011 Mar; 10(2):159-69. PubMed ID: 21174613
[TBL] [Abstract][Full Text] [Related]
10. [Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancer].
Sauter C; Saborowski A; Ockenfels HM
Hautarzt; 2007 Jul; 58(7):619-22. PubMed ID: 17066280
[TBL] [Abstract][Full Text] [Related]
11. High frequency of hand foot syndrome with capecitabine.
Kamil M; Haron M; Yosuff N; Khalid I; Azman N
J Coll Physicians Surg Pak; 2010 Jun; 20(6):421-2. PubMed ID: 20642979
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal melanonychia induced by capecitabine.
Paravar T; Hymes SR
Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
[TBL] [Abstract][Full Text] [Related]
13. [Blisters unlike others].
Gugerli O; Leupin N
Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
[No Abstract] [Full Text] [Related]
14. [A case of severe hand-foot syndrome caused by capecitabine].
Shimomatsuya T; Mitsudou Y; Nakamura T; Yonezawa K; Shiraishi S; Fujino M; Maruhashi K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1139-41. PubMed ID: 17637558
[TBL] [Abstract][Full Text] [Related]
15. Study of low-dose capecitabine monotherapy for metastatic breast cancer.
Taguchi T; Nakayama T; Masuda N; Yoshidome K; Akagi K; Nishida Y; Yoshikawa Y; Ogino N; Abe C; Sakamoto J; Noguchi S;
Chemotherapy; 2010; 56(2):166-70. PubMed ID: 20407245
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
Chua D; Wei WI; Sham JS; Au GK
Jpn J Clin Oncol; 2008 Apr; 38(4):244-9. PubMed ID: 18407933
[TBL] [Abstract][Full Text] [Related]
17. A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
Caronia D; Martin M; Sastre J; de la Torre J; García-Sáenz JA; Alonso MR; Moreno LT; Pita G; Díaz-Rubio E; Benítez J; González-Neira A
Clin Cancer Res; 2011 Apr; 17(7):2006-13. PubMed ID: 21325291
[TBL] [Abstract][Full Text] [Related]
18. Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer.
Yoshimoto N; Yamashita T; Fujita T; Hayashi H; Tsunoda N; Kimura M; Tsuzuki N; Yamashita H; Toyama T; Kondo N; Iwata H
Breast Cancer; 2010 Oct; 17(4):298-302. PubMed ID: 19789949
[TBL] [Abstract][Full Text] [Related]
19. Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer.
Vickers MM; Easaw JC
J Gastrointest Cancer; 2008; 39(1-4):141-3. PubMed ID: 19440857
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study.
Kang YK; Lee SS; Yoon DH; Lee SY; Chun YJ; Kim MS; Ryu MH; Chang HM; Lee JL; Kim TW
J Clin Oncol; 2010 Aug; 28(24):3824-9. PubMed ID: 20625131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
